Loading...
Zydus Lifesciences Limited — Mercaptopurine Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #7 for Mercaptopurine · $19.8K export value · DGFT Verified
Zydus Lifesciences Limited is the #7 Indian exporter of Mercaptopurine with $19.8K in export value and 5 verified shipments. Zydus Lifesciences Limited holds a 3.4% market share in Mercaptopurine exports across 2 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| COLOMBIA | $217.0K | 8 | 43.5% |
| INDONESIA | $65.3K | 11 | 13.1% |
| ETHIOPIA | $39.8K | 5 | 8.0% |
| KYRGYZSTAN | $26.5K | 7 | 5.3% |
| SRI LANKA | $25.4K | 22 | 5.1% |
| KAZAKHSTAN | $24.9K | 6 | 5.0% |
| YEMEN | $16.7K | 16 | 3.4% |
| EGYPT | $13.6K | 6 | 2.7% |
| LEBANON | $11.6K | 14 | 2.3% |
| MOROCCO | $11.6K | 2 | 2.3% |
India exports Mercaptopurine to 75 countries. The top destination is COLOMBIA (43.5%), followed by INDONESIA and ETHIOPIA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FELIRNI LABS SAS | COLOMBIA | $214.9K | 7 |
| COMMERCIAL BANK OF ETHIOPIA | ETHIOPIA | $39.2K | 2 |
| KIMIA FARMA TBK PT JALAN VETERAN NOMOR | INDONESIA | $27.0K | 2 |
| SOFTCARE INTERNATIONAL(PVT)LTD | SRI LANKA | $22.7K | 6 |
| ALSHAMELAH FOR TRADING | JORDAN | $14.2K | 5 |
| BOTTU S A | MOROCCO | $11.6K | 2 |
India exported $426.2K worth of Mercaptopurine through 504 shipments from 115 suppliers to 75 countries, serving 163 buyers globally. Zydus Lifesciences Limited contributes $19.8K to this total, accounting for 3.4% of India's Mercaptopurine exports.
Zydus Lifesciences Limited's average Mercaptopurine shipment value is $4.0K per consignment, based on 5 shipments totaling $19.8K.
Zydus Lifesciences Limited ranks #7 among 115 Indian Mercaptopurine exporters with a 3.4% market share. The top 3 exporters are BETA DRUGS LIMITED ($232.5K), NEON LABORATORIES LIMITED ($40.5K), CADILA HEALTHCARE LTD ($28.3K). Zydus Lifesciences Limited processed 5 shipments to 2 destination countries.
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | BIOZENTA LIFESCIENCE PRIVATE LIMITED | $23.6K | 3 | 3 | $7.9K |
| 6 | JODAS EXPOIM PRIVATE LIMITED | $22.8K | 7 | 1 | $3.3K |
| 7 | ZYDUS LIFESCIENCES LIMITED ★ | $19.8K | 5 | 2 | $4.0K |
| 8 | GENEX PHARMA | $13.1K | 16 | 5 | $818 |
| 9 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 126 | 25.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 97 | 19.2% |
| DELHI AIR | 86 | 17.1% |
| DELHI AIR CARGO ACC (INDEL4) | 56 | 11.1% |
| Bombay Air | 31 | 6.2% |
| Bombay Air Cargo | 12 | 2.4% |
| Delhi Air | 10 | 2.0% |
| AHEMDABAD AIR | 9 | 1.8% |
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Mercaptopurine, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Mercaptopurine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Mercaptopurine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
| ESSENCE LIFE |
| LEBANON |
| $8.6K |
| 5 |
| CONCERNED PERSON LLC | KAZAKHSTAN | $7.0K | 3 |
| ROYAL PHARMA CO. | EGYPT | $6.4K | 2 |
India's Mercaptopurine is purchased by 163 buyers worldwide. The top buyer is FELIRNI LABS SAS (COLOMBIA), followed by COMMERCIAL BANK OF ETHIOPIA and KIMIA FARMA TBK PT JALAN VETERAN NOMOR.
| AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED |
| $10.5K |
| 4 |
| 1 |
| $2.6K |
Zydus Lifesciences Limited ranks #7 among 115 Indian Mercaptopurine exporters. Average shipment value of $4.0K compared to the market average of $3.7K. The closest competitors by value are BIOZENTA LIFESCIENCE PRIVATE LIMITED and JODAS EXPOIM PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 75+ countries, 163+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mercaptopurine. For current shipment-level data, contact TransData Nexus.